Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP324612.RAHzmh2d4DJ_Y8A8hORhgodgWDeyDbXjTBP8rzNxuGQLQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP324612.RAHzmh2d4DJ_Y8A8hORhgodgWDeyDbXjTBP8rzNxuGQLQ130_assertion type Assertion NP324612.RAHzmh2d4DJ_Y8A8hORhgodgWDeyDbXjTBP8rzNxuGQLQ130_head.
- NP324612.RAHzmh2d4DJ_Y8A8hORhgodgWDeyDbXjTBP8rzNxuGQLQ130_assertion description "[Drug resistance in AML is multifactorial but can be associated with the overexpression of transmembrane transporter molecules, including P-glycoprotein (Pgp) or the multidrug resistance-associated protein (MRP), or associated with inactivation of the p53 tumor suppressor gene, as well as overexpression of the anti-apoptotic protein bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP324612.RAHzmh2d4DJ_Y8A8hORhgodgWDeyDbXjTBP8rzNxuGQLQ130_provenance.
- NP324612.RAHzmh2d4DJ_Y8A8hORhgodgWDeyDbXjTBP8rzNxuGQLQ130_assertion evidence source_evidence_literature NP324612.RAHzmh2d4DJ_Y8A8hORhgodgWDeyDbXjTBP8rzNxuGQLQ130_provenance.
- NP324612.RAHzmh2d4DJ_Y8A8hORhgodgWDeyDbXjTBP8rzNxuGQLQ130_assertion SIO_000772 9168435 NP324612.RAHzmh2d4DJ_Y8A8hORhgodgWDeyDbXjTBP8rzNxuGQLQ130_provenance.
- NP324612.RAHzmh2d4DJ_Y8A8hORhgodgWDeyDbXjTBP8rzNxuGQLQ130_assertion wasDerivedFrom befree-20140225 NP324612.RAHzmh2d4DJ_Y8A8hORhgodgWDeyDbXjTBP8rzNxuGQLQ130_provenance.
- NP324612.RAHzmh2d4DJ_Y8A8hORhgodgWDeyDbXjTBP8rzNxuGQLQ130_assertion wasGeneratedBy ECO_0000203 NP324612.RAHzmh2d4DJ_Y8A8hORhgodgWDeyDbXjTBP8rzNxuGQLQ130_provenance.